These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 20037466)
1. Target validation using Phase 0 clinical trials: Promises and pitfalls. Angelo LS; Kurzrock R Cancer Biol Ther; 2009 Nov; 8(21):2010-2. PubMed ID: 20037466 [No Abstract] [Full Text] [Related]
2. Translational research in clinical trials: the only way forward. Eggermont A; Newell H Eur J Cancer; 2001 Nov; 37(16):1965. PubMed ID: 11699495 [No Abstract] [Full Text] [Related]
3. The Evolution of Clinical Trials in Oncology: Defining Who Benefits from New Drugs Using Innovative Study Designs. Goldberg RM; Wei L; Fernandez S Oncologist; 2017 Sep; 22(9):1015-1019. PubMed ID: 28620092 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant trials could speed up drug approvals. Peres J J Natl Cancer Inst; 2014 Mar; 106(3):dju072. PubMed ID: 24610911 [No Abstract] [Full Text] [Related]
5. Can single-patient investigational new drug studies hurry slow trains to the fast track? Chenoweth D Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594 [TBL] [Abstract][Full Text] [Related]
11. Slow start to phase 0 as researchers debate value. Twombly R J Natl Cancer Inst; 2006 Jun; 98(12):804-6. PubMed ID: 16788150 [No Abstract] [Full Text] [Related]
12. American society of clinical oncology - 45th annual meeting. Part 1. Gale S IDrugs; 2009 Jul; 12(7):401-3. PubMed ID: 19579154 [No Abstract] [Full Text] [Related]
13. American society of clinical oncology - 45th annual meeting. Part 2. Lakeram M; Kibble A IDrugs; 2009 Jul; 12(7):404-8. PubMed ID: 19579155 [No Abstract] [Full Text] [Related]
14. SOP 06: Selecting the participating centers and activation of a trial. Onkologie; 2003 Oct; 26 Suppl 6():34-5. PubMed ID: 23570182 [No Abstract] [Full Text] [Related]